Healthcare provider profile · identity verified

John Franklin Simmons, M.D

Allopathic & Osteopathic Physicians|General Practice · GENEVA, AL · NPI 1922045905

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show John Franklin Simmons, M.D received $234.35 in general payments during 2025 across 9 reported records.

Lilly USA, LLC accounted for 37.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 145 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 33 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$234.35

9 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$87.24	37.2%	1	2025
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	Unresolved — no canonical attribution shown	$75.96	32.4%	4	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$28.89	12.3%	2	2025
Sumitomo Pharma America, Inc.	Unresolved — no canonical attribution shown	$25.99	11.1%	1	2025
Averitas Pharma Inc.	Unresolved — no canonical attribution shown	$16.27	6.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$234.35	9

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$87.24	1	2025
Source payment records 2025-05-08 · Lilly USA, LLC · $87.24 · Open Payments source
CAPLYTA Normalized: caplyta	Drug	ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)	$75.96	4	2025
Source payment records 2025-06-23 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $23.96 · Open Payments source 2025-09-08 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $17.57 · Open Payments source 2025-10-06 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $14.16 · Open Payments source 2025-12-01 · ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) · $20.27 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$28.89	2	2025
Source payment records 2025-06-03 · Exact Sciences Corporation · $14.07 · Open Payments source 2025-09-25 · Exact Sciences Corporation · $14.82 · Open Payments source
GEMTESA Normalized: gemtesa	Drug	Sumitomo Pharma America, Inc.	$25.99	1	2025
Source payment records 2025-08-25 · Sumitomo Pharma America, Inc. · $25.99 · Open Payments source
QUTENZA Normalized: qutenza	Drug	Averitas Pharma Inc.	$16.27	1	2025
Source payment records 2025-05-05 · Averitas Pharma Inc. · $16.27 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	145	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	51	12
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	145	26
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	33	11

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	522	161
Levothyroxine Sodium	Levothyroxine Sodium	473	116
Lisinopril	Lisinopril	441	130
Losartan Potassium	Losartan Potassium	354	104
Amlodipine Besylate	Amlodipine Besylate	351	106
Metoprolol Succinate	Metoprolol Succinate	350	96
Simvastatin	Simvastatin	333	88
Tramadol Hcl	Tramadol Hcl	324	99
Gabapentin	Gabapentin	311	95
Furosemide	Furosemide	270	94
Alendronate Sodium	Alendronate Sodium	251	84
Valsartan	Valsartan	249	66
Pantoprazole Sodium	Pantoprazole Sodium	245	78
Omeprazole	Omeprazole	241	85
Tamsulosin Hcl	Tamsulosin Hcl	241	71
Alprazolam	Alprazolam	219	50
Meloxicam	Meloxicam	206	75
Sertraline Hcl	Sertraline Hcl	199	56
Donepezil Hcl	Donepezil Hcl	188	50
Rosuvastatin Calcium	Rosuvastatin Calcium	188	51
Trazodone Hcl	Trazodone Hcl	185	43
Farxiga	Dapagliflozin Propanediol	169	32
Famotidine	Famotidine	163	55
Prednisone	Prednisone	159	92
Clopidogrel	Clopidogrel Bisulfate	158	45
Montelukast Sodium	Montelukast Sodium	156	55
Clonazepam	Clonazepam	155	33
Metoprolol Tartrate	Metoprolol Tartrate	153	43
Duloxetine Hcl	Duloxetine Hcl	152	36
Bumetanide	Bumetanide	145	41
Mounjaro	Tirzepatide	145	26
Ozempic	Semaglutide	134	22
Eliquis	Apixaban	132	28
Ropinirole Hcl	Ropinirole Hcl	132	32
Zolpidem Tartrate	Zolpidem Tartrate	127	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	126	42
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	118	32
Albuterol Sulfate Hfa	Albuterol Sulfate	117	51
Hydrochlorothiazide	Hydrochlorothiazide	116	38
Metformin Hcl	Metformin Hcl	116	39
Mirtazapine	Mirtazapine	115	20
Potassium Chloride	Potassium Chloride	112	40
Temazepam	Temazepam	112	28
Vitamin D2	Ergocalciferol (Vitamin D2)	109	33
Escitalopram Oxalate	Escitalopram Oxalate	108	26
Memantine Hcl	Memantine Hcl	106	26
Fluoxetine Hcl	Fluoxetine Hcl	104	29
Fluticasone Propionate	Fluticasone Propionate	102	58
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	101	15
Clonidine Hcl	Clonidine Hcl	100	30
Glimepiride	Glimepiride	100	28
Januvia	Sitagliptin Phosphate	98	20
Spironolactone	Spironolactone	97	34
Oxcarbazepine	Oxcarbazepine	91	21
Hydralazine Hcl	Hydralazine Hcl	90	21
Venlafaxine Hcl Er	Venlafaxine Hcl	90	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	30
Topiramate	Topiramate	88	19
Allopurinol	Allopurinol	86	31
Tizanidine Hcl	Tizanidine Hcl	86	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	82	64
Levofloxacin	Levofloxacin	82	72
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	25
Buspirone Hcl	Buspirone Hcl	81	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	80	24
Pregabalin	Pregabalin	79	33
Metformin Hcl Er	Metformin Hcl	78	26
Ondansetron Hcl	Ondansetron Hcl	77	52
Cilostazol	Cilostazol	74	22
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	74	26
Lorazepam	Lorazepam	74	29
Finasteride	Finasteride	72	27
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	72	18
Isosorbide Mononitrate Er	Isosorbide Mononitrate	71	18
Nortriptyline Hcl	Nortriptyline Hcl	71	21
Carvedilol	Carvedilol	70	26
Bupropion Hcl Sr	Bupropion Hcl	68	21
Myrbetriq	Mirabegron	66	17
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	64	22
Fenofibrate	Fenofibrate Nanocrystallized	63	19
Xarelto	Rivaroxaban	62	19
Citalopram Hbr	Citalopram Hydrobromide	61	23
Digoxin	Digoxin	61	24
Esomeprazole Magnesium	Esomeprazole Magnesium	61	14
Amoxicillin	Amoxicillin	59	51
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	58	50
Fluconazole	Fluconazole	58	48
Pravastatin Sodium	Pravastatin Sodium	57	20
Alfuzosin Hcl Er	Alfuzosin Hcl	56	18
Hydroxyzine Hcl	Hydroxyzine Hcl	54	17
Propranolol Hcl	Propranolol Hcl	54	18
Midodrine Hcl	Midodrine Hcl	52	12
Jardiance	Empagliflozin	51	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	51	13
Diclofenac Sodium	Diclofenac Sodium	49	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	42
Warfarin Sodium	Warfarin Sodium	47	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	46	18
Ramipril	Ramipril	46	15
Baclofen	Baclofen	45	15
Glipizide	Glipizide	45	14
Diazepam	Diazepam	43	suppressed
Ibuprofen	Ibuprofen	43	21
Breo Ellipta	Fluticasone/Vilanterol	42	suppressed
Estradiol	Estradiol	42	15
Levetiracetam	Levetiracetam	42	12
Terazosin Hcl	Terazosin Hcl	42	16
Mupirocin	Mupirocin	41	31
Paroxetine Hcl	Paroxetine Hcl	41	14
Azithromycin	Azithromycin	39	36
Celecoxib	Celecoxib	39	suppressed
Dexamethasone	Dexamethasone	39	37
Olanzapine	Olanzapine	39	suppressed
Eszopiclone	Eszopiclone	37	suppressed
Meclizine Hcl	Meclizine Hcl	37	23
Metoclopramide Hcl	Metoclopramide Hcl	37	17
Quetiapine Fumarate	Quetiapine Fumarate	37	15
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Cefdinir	Cefdinir	36	33
Entresto	Sacubitril/Valsartan	36	suppressed
Methocarbamol	Methocarbamol	36	22
Ezetimibe	Ezetimibe	35	suppressed
Novolog	Insulin Aspart	35	suppressed
Theophylline Er	Theophylline Anhydrous	35	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Clindamycin Hcl	Clindamycin Hcl	33	31
Ondansetron Odt	Ondansetron	33	21
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Quviviq	Daridorexant Hcl	33	suppressed
Trulicity	Dulaglutide	33	11
Doxycycline Hyclate	Doxycycline Hyclate	32	28
Levemir	Insulin Detemir	30	suppressed
Methylprednisolone	Methylprednisolone	30	26
Risperidone	Risperidone	30	suppressed
Cephalexin	Cephalexin	29	26
Methotrexate	Methotrexate Sodium	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	18
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Nitroglycerin	Nitroglycerin	28	21
Sumatriptan Succinate	Sumatriptan Succinate	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	12
Gemfibrozil	Gemfibrozil	26	suppressed
Nifedipine Er	Nifedipine	26	11
Nystatin	Nystatin	26	17
Primidone	Primidone	26	suppressed
Ranolazine Er	Ranolazine	26	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	25	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	18
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	23	19
Naltrexone Hcl	Naltrexone Hcl	23	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	22	suppressed
Lactulose	Lactulose	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Sucralfate	Sucralfate	22	13
Diltiazem Hcl	Diltiazem Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Minoxidil	Minoxidil	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Dapagliflozin	Dapagliflozin Propanediol	20	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Ursodiol	Ursodiol	20	suppressed
Atenolol	Atenolol	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Linzess	Linaclotide	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Haloperidol	Haloperidol	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	12
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Dapsone	Dapsone	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	14	suppressed
Insulin Aspart	Insulin Aspart	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Emgality Pen	Galcanezumab-Gnlm	13	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	13	suppressed
Letrozole	Letrozole	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Calcium Acetate	Calcium Acetate	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	12	suppressed
Metronidazole	Metronidazole	12	11
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Clarithromycin Er	Clarithromycin	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Econazole Nitrate	Econazole Nitrate	11	suppressed
Fluorouracil	Fluorouracil	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Methimazole	Methimazole	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$234.35 · 9 records	Lilly USA, LLC	CAPLYTA, Cologuard Collection Kit, GEMTESA, MOUNJARO, QUTENZA	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error